Amy Rosen to Cost-Benefit Analysis
This is a "connection" page, showing publications Amy Rosen has written about Cost-Benefit Analysis.
Connection Strength
0.053
-
Rosen A, Wu J, Chang BH, Berlowitz D, Ash A, Moskowitz M. Does diagnostic information contribute to predicting functional decline in long-term care? Med Care. 2000 Jun; 38(6):647-59.
Score: 0.039
-
Wu EQ, Birnbaum HG, Mareva MN, Le TK, Robinson RL, Rosen A, Gelwicks S. Cost-effectiveness of duloxetine versus routine treatment for U.S. patients with diabetic peripheral neuropathic pain. J Pain. 2006 Jun; 7(6):399-407.
Score: 0.015